Aurinia Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $70,008 | $62,465 | $59,867 | $67,771 |
Gross Profit | 62,893 | 53,891 | 54,315 | 61,736 |
EBITDA | 28,137 | 30,272 | 7,181 | 20,908 |
EBIT | 23,273 | 25,416 | 2,319 | 16,015 |
Net Income | 21,513 | 23,344 | 1,429 | 14,350 |
Net Change In Cash | 70,008 | 62,465 | 59,867 | 67,771 |
Free Cash Flow | 44,143 | 1,283 | 30,058 | 16,900 |
Cash | 53,002 | 66,428 | 83,433 | 37,142 |
Basic Shares | 143,199 | 143,199 | 147,675 | 145,651 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $235,133 | $175,513 | $134,030 | $45,605 |
Gross Profit | 206,885 | 161,365 | 128,366 | 44,514 |
EBITDA | 31,728 | -63,047 | -108,764 | -177,445 |
EBIT | 12,283 | -74,694 | -111,470 | -180,206 |
Net Income | 5,752 | -78,020 | -108,180 | -180,966 |
Net Change In Cash | 235,133 | 175,513 | 134,030 | 45,605 |
Cost of Revenue | -40,450 | |||
Free Cash Flow | 44,107 | -34,179 | -79,821 | -159,193 |
Cash | 83,433 | 48,875 | 94,172 | 231,900 |
Basic Shares | 146,194 | 143,236 | 141,915 | 129,369 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.16 |
2025-03-31 | $0.16 |
2024-12-31 | $0.01 |
